Title:
HETEROCYCLIC COMPOUND CCR4 INHIBITOR AND USER THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/232130
Kind Code:
A1
Abstract:
Disclosed in the present invention are a heterocyclic compound as shown in formula (I) or a stereoisomer, deuterated compound, solvate, pharmaceutically acceptable salt, or co-crystal thereof and a pharmaceutical composition thereof, and a use thereof in the preparation of a drug for treating/preventing CCR4-mediated diseases. Groups in formula (I) are as defined in the description.
More Like This:
Inventors:
LI YAO (CN)
ZHANG GUOBIAO (CN)
CHEN LEI (CN)
ZHANG XIAOBO (CN)
HU GANG (CN)
GENG PENGXIN (CN)
LI WENFEI (CN)
YAO HAO (CN)
HUANG SHILIN (CN)
ZHANG YAMING (CN)
YAN LINJIE (CN)
TANG PINGMING (CN)
TANG YINGDE (CN)
ZHANG CHEN (CN)
YAN PANGKE (CN)
ZHANG GUOBIAO (CN)
CHEN LEI (CN)
ZHANG XIAOBO (CN)
HU GANG (CN)
GENG PENGXIN (CN)
LI WENFEI (CN)
YAO HAO (CN)
HUANG SHILIN (CN)
ZHANG YAMING (CN)
YAN LINJIE (CN)
TANG PINGMING (CN)
TANG YINGDE (CN)
ZHANG CHEN (CN)
YAN PANGKE (CN)
Application Number:
PCT/CN2023/097926
Publication Date:
December 07, 2023
Filing Date:
June 02, 2023
Export Citation:
Assignee:
TIBET HAISCO PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D401/14; A61P29/00; A61P35/00; C07D495/04
Domestic Patent References:
| WO2005123697A1 | 2005-12-29 |
Foreign References:
| CN111971279A | 2020-11-20 | |||
| CN111918652A | 2020-11-10 | |||
| CN109640988A | 2019-04-16 | |||
| US20050261496A1 | 2005-11-24 |
Other References:
SUN ZHAO-HUI, WE JU: "CC Chemokine Receptor 4 and Its Inhibitors: Research Advances", JOURNAL OF INTERNATIONAL PHARMACEUTICAL RESEARCH, JUNSHI YIXUE KEXUEYUAN * DUWU YAOWU JIANJIUSUO, CN, vol. 37, no. 1, 28 February 2010 (2010-02-28), CN , pages 29 - 31, XP009551005, ISSN: 1674-0440, DOI: 10.13220/j.cnki.jipr.2010.01.007
Attorney, Agent or Firm:
BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: